These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38847670)
1. Clinical significance of serum Ck18-M65 and M30 levels in patients with chronic hepatitis B combined with nonalcoholic steatohepatitis and liver fibrosis. Dai L; Yan Y; Chen Q Medicine (Baltimore); 2024 Jun; 103(23):e38342. PubMed ID: 38847670 [TBL] [Abstract][Full Text] [Related]
2. The expression of serum M30 and M65 in chronic hepatitis B patients with non-alcoholic fatty liver disease. Liang J; Han T; Gao YT; Jing L; Ma Z Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4123-9. PubMed ID: 26592838 [TBL] [Abstract][Full Text] [Related]
3. Cell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B: A cross-sectional study of diagnostic accuracy. Wei X; Wei H; Lin W; Hu Z; Zhang J Medicine (Baltimore); 2017 May; 96(20):e6807. PubMed ID: 28514295 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure. Zheng SJ; Liu S; Liu M; McCrae MA; Li JF; Han YP; Xu CH; Ren F; Chen Y; Duan ZP World J Gastroenterol; 2014 Mar; 20(9):2403-11. PubMed ID: 24605039 [TBL] [Abstract][Full Text] [Related]
5. Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH. Pimentel CF; Jiang ZG; Otsubo T; Feldbrügge L; Challies TL; Nasser I; Robson S; Afdhal N; Lai M Dig Dis Sci; 2016 Mar; 61(3):905-12. PubMed ID: 26462489 [TBL] [Abstract][Full Text] [Related]
6. Relationship between liver injury and serum cytokeratin 18 levels in asymptomatic hepatitis B virus carriers and in patients with chronic hepatitis B infection. Balkan A; Yılmaz N; Balkan Y; Koruk I; Örkmez M; Aydınlı M; Koruk M Arab J Gastroenterol; 2017 Jun; 18(2):98-103. PubMed ID: 28579343 [TBL] [Abstract][Full Text] [Related]
7. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. Yilmaz Y; Dolar E; Ulukaya E; Akgoz S; Keskin M; Kiyici M; Aker S; Yilmaztepe A; Gurel S; Gulten M; Nak SG World J Gastroenterol; 2007 Feb; 13(6):837-44. PubMed ID: 17352011 [TBL] [Abstract][Full Text] [Related]
8. (Cleaved) CK18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allografts. Reis H; Wohlschläger J; Hagemann S; Wenzel P; Bechmann LP; Suttorp AC; Schlattjan MJ; Herzer K; Canbay A; Baba HA Liver Int; 2015 Mar; 35(3):905-13. PubMed ID: 24750688 [TBL] [Abstract][Full Text] [Related]
9. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients. Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434 [TBL] [Abstract][Full Text] [Related]
10. Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis. Lee J; Vali Y; Boursier J; Duffin K; Verheij J; Brosnan MJ; Zwinderman K; Anstee QM; Bossuyt PM; Zafarmand MH PLoS One; 2020; 15(9):e0238717. PubMed ID: 32915852 [TBL] [Abstract][Full Text] [Related]
12. Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease. Mueller S; Nahon P; Rausch V; Peccerella T; Silva I; Yagmur E; Straub BK; Lackner C; Seitz HK; Rufat P; Sutton A; Bantel H; Longerich T Hepatology; 2017 Jul; 66(1):96-107. PubMed ID: 28170108 [TBL] [Abstract][Full Text] [Related]
13. A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis. Younossi ZM; Page S; Rafiq N; Birerdinc A; Stepanova M; Hossain N; Afendy A; Younoszai Z; Goodman Z; Baranova A Obes Surg; 2011 Apr; 21(4):431-9. PubMed ID: 20532833 [TBL] [Abstract][Full Text] [Related]
14. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. Ergelen R; Akyuz U; Aydin Y; Eren F; Yilmaz Y Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):667-71. PubMed ID: 25923941 [TBL] [Abstract][Full Text] [Related]
15. Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels. Zheng KI; Liu WY; Pan XY; Ma HL; Zhu PW; Wu XX; Targher G; Byrne C; Wang XD; Chen YP; Lu F; Zheng MH BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32139603 [TBL] [Abstract][Full Text] [Related]